InterVene
InterVene: A medical device startup revolutionizing treatment for severe venous leg disease.
InterVene: A medical device startup revolutionizing treatment for severe venous leg disease.
InterVene, founded with a mission to revolutionize the treatment of severe venous disease in the legs, is a medical device startup focused on addressing chronic venous insufficiency. The company has developed Chronus™, an innovative interventional technology designed to efficiently de-bulk and recanalize chronic post-thrombotic venous occlusions and obstructions. InterVene aims to provide comprehensive solutions for chronic venous issues, significantly improving patient outcomes in this specialized medical field.
Notable affiliated individuals and investors include experienced professionals in the medical device industry and venture capital firms specializing in healthcare innovations. InterVene's key achievements include the development and investigational use of Chronus™, which has shown promise in clinical settings. Although still under investigation and not yet approved for sale worldwide, the company's pioneering approach has the potential to make a significant impact on the treatment landscape for chronic venous insufficiency, offering new hope to patients suffering from this debilitating condition.
Companies similar to InterVene include Traverse Vascular, Inari Medical, Venarum Medical and enVVeno Medical.
InterVene was founded in 2011.
InterVene's headquarters is located in South San Francisco, CA, US.
InterVene's most recent funding round was for $15M (USD) in June 2019.
As of Jun 25, 2019, InterVene has disclosed funding of $20.9M (USD). Undisclosed round amounts are excluded.
InterVene has 17 employees as of Feb 4, 2024.
enVVeno Medical
envveno.com
